01 July 2005 : Extended abstract from EFAS 2011
Med Sci Monit 2005; 11(7): BR228-234 :: ID: 16975
Background: Curcumin (a component of turmeric) has long been used as aspice and food-coloring agent. In experimental animals, curcumin has shown anti-diabetic, anti-inflammatory,cytotoxic and anti-oxidant properties. Material/Methods: The possible hypolipidemic effect of curcuminwas investigated in rats fed a high-cholesterol diet (HCD). The lipid profile and activities of aspartateaminotransferase (AST) and alanine aminotransferase (ALT) were assessed in serum, as well as anti-oxidantparameters in liver tissues. Results: Feeding the animals a high cholesterol diet (HCD) for 7 consecutivedays (1 ml 100 g(-1)) resulted in marked hypercholesterolemia, increased serum level of low-density lipoproteincholesterol (LDL-C), but a decreased serum high-density lipoprotein cholesterol (HDL-C). Curcumin admixedwith the diet (0.5% w/w) decreased serum total cholesterol (TC) by about 21% and LDL-C by 42.5%, butit increased serum HDL by 50%. The atherogenic indices (LDL-C/HDL-C and TC/HDL-C) were reduced by 52%and 35%, respectively. Curcumin also decreased the enzyme activities of serum AST and ALT, which wereincreased in HCD animals. Conclusions: Curcumin showed an obvious hypocholesterolemic effect that couldbe due to an effect on cholesterol absorption, degradation or elimination, but not due to an anti-oxidantmechanism. This could be supported by the finding in our study that neither HCD nor curcumin-admixedHCD had any effects on the liver content of glutathione (GSH) or superoxide dismutase (SOD) activity.Thus one could argue that ingestion of curcumin-containing spices in the diet, especially one rich infats, could have a lipid-lowering effect.
Keywords: Alanine Transaminase - antagonists & inhibitors, Aspartate Aminotransferases - antagonists & inhibitors, Curcumin - therapeutic use, Alanine Transaminase - antagonists & inhibitors, Animals, Aspartate Aminotransferases - antagonists & inhibitors, Cholesterol - blood, Cholesterol, Dietary - adverse effects, Cholesterol, HDL - blood, Cholesterol, LDL - blood, Curcumin - therapeutic use, Hypercholesterolemia - etiology, Hypolipidemic Agents - therapeutic use, Liver - enzymology, Rats
01 January 2022 : EditorialEditorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Patients
Med Sci Monit 2022; 28:e935952
11 January 2022 : Clinical ResearchA Remote Questionnaire-Based Study to Compare Alcohol Use in 1030 Final-Year High School Students in Split-...
Med Sci Monit In Press; DOI: 10.12659/MSM.935567
08 November 2021 : Database AnalysisVirtual Screening and Molecular Docking to Study the Mechanism of Chinese Medicines in the Treatment of Cor...
Med Sci Monit In Press; DOI: 10.12659/MSM.934102
31 December 2021 : Clinical ResearchA Prospective Observational Study of 42 Patients with COVID-19 infection and a History of Hepatitis C Virus...
Med Sci Monit 2021; 27:e935075
14 Jan 2022 : Database AnalysisIdentification of Key Genes Associated with Brain Metastasis from Breast Cancer: A Bioinformatics Analysis
Med Sci Monit In Press; DOI: 10.12659/MSM.935071
13 Jan 2022 : Review articleA Review of Current Clinical Concepts in the Pathophysiology, Etiology, Diagnosis, and Management of Hyperc...
Med Sci Monit In Press; DOI: 10.12659/MSM.935821
13 Jan 2022 : Clinical ResearchEffect of Cerebral Microbleeds on Cognitive Function and Quality of Life in Parkinson Disease
Med Sci Monit In Press; DOI: 10.12659/MSM.935026
Most Viewed Current Articles
30 Dec 2021 : Clinical ResearchRetrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...
Med Sci Monit 2021; 27:e935379
01 Nov 2020 : Review articleLong-Term Respiratory and Neurological Sequelae of COVID-19
Med Sci Monit 2020; 26:e928996
05 Mar 2020 : Clinical ResearchThe Effects of Social Support on Sleep Quality of Medical Staff Treating Patients with Coronavirus Disease ...
Med Sci Monit 2020; 26:e923549